New research from investigators in the U.K. has shown that markers of brain injury are present many months after COVID-19 infection, despite standard blood testing that is normal. The research, published in Nature Communications, helps provide potential therapy pathways for patients that experience cognitive difficulties after recovering from COVID-19 by indicating that these ongoing symptoms are likely due to dysregulation of the innate and adaptive immune response to the SARS-CoV-2 virus and not direct infiltration of the central nervous system.

http://tinyurl.com/32a6ecbc

AND

Nature Communications – Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

https://www.nature.com/articles/s41467-023-42320-4